Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma
…, JH Galicich, G Krol, E Arbit, MG Malkin - International Journal of …, 1989 - Elsevier
Recurrence patterns of glioblastoma multiforme (25) and anaplastic astrocytoma (9) were
studied using CT scans of 34 patients who received all or a portion of their surgical treatment …
studied using CT scans of 34 patients who received all or a portion of their surgical treatment …
Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity
BM Ellingson, MG Malkin, SD Rand… - Journal of Magnetic …, 2010 - Wiley Online Library
Purpose: To present comprehensive examinations of the assumptions made in functional
diffusion map (fDM) analyses and provide a biological basis for fDM classification. Materials …
diffusion map (fDM) analyses and provide a biological basis for fDM classification. Materials …
Handheld cellular telephone use and risk of brain cancer
JE Muscat, MG Malkin, S Thompson, RE Shore… - Jama, 2000 - jamanetwork.com
ContextA relative paucity of data exist on the possible health effects of using cellular
telephones.ObjectiveTo test the hypothesis that using handheld cellular telephones is related to the …
telephones.ObjectiveTo test the hypothesis that using handheld cellular telephones is related to the …
The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial …
…, VC Arena, JC Van Gilder, J Wu, MG Malkin… - …, 2002 - journals.lww.com
OBJECTIVE: The objective of the Brain Tumor Cooperative Group NIH Trial 87-01 trial was
to investigate the effect of additional implanted radiation therapy in newly diagnosed patients …
to investigate the effect of additional implanted radiation therapy in newly diagnosed patients …
A phase II trial of temozolomide for patients with recurrent or progressive brain metastases
…, M Mack, A Rodavitch, DY Boutros, MG Malkin - Journal of neuro …, 2001 - Springer
Background: Treatment options for patients with recurrent brain metastases are extremely
limited. This study was designed to determine the safety and efficacy of temozolomide in the …
limited. This study was designed to determine the safety and efficacy of temozolomide in the …
Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma
…, SD Rand, RG Hoffman, W Mueller, MG Malkin - Neuro …, 2014 - academic.oup.com
Background The anti-VEGF antibody, bevacizumab, is standard treatment for patients with
recurrent glioblastoma. In this setting, traditional anatomic MRI methods such as post-contrast …
recurrent glioblastoma. In this setting, traditional anatomic MRI methods such as post-contrast …
The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma
R Lai, CT Dang, MG Malkin, LE Abrey - Cancer, 2004 - Wiley Online Library
BACKGROUND Trastuzumab, which is a large monoclonal antibody that is efficacious in the
treatment of patients with HER‐2/neu‐overexpressing, metastatic breast carcinoma, does …
treatment of patients with HER‐2/neu‐overexpressing, metastatic breast carcinoma, does …
Systemic high-dose intravenous methotrexate for central nervous system metastases
…, KS Panageas, M Begemann, MG Malkin… - Journal of neuro …, 2006 - Springer
Background Treatment options for patients with recurrent central nervous system (CNS)
metastases are limited. Rapid infusion of high-dose intravenous methotrexate (HD IV MTX) …
metastases are limited. Rapid infusion of high-dose intravenous methotrexate (HD IV MTX) …
Environmental risk factors for brain tumors
JM Connelly, MG Malkin - Current neurology and neuroscience reports, 2007 - Springer
Primary brain tumors, whether malignant or nonmalignant, have devastating consequences.
Unfortunately, few known causes exist. Despite decades of epidemiologic research to …
Unfortunately, few known causes exist. Despite decades of epidemiologic research to …
Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high …
…, SD Rand, J Connelly, JA Bovi, MG Malkin… - Neuro …, 2014 - academic.oup.com
Background Recent conflicting reports have found both brain tumor hypercellularity and
necrosis in regions of restricted diffusion on MRI-derived apparent diffusion coefficient (ADC) …
necrosis in regions of restricted diffusion on MRI-derived apparent diffusion coefficient (ADC) …
